How about all we frustrated Starpharma shareholders start offering SPL our services to participate in human trials of Virileze. Don't think we can come to much harm. There does not appear to have been any reports of adverse reactions from UK and European users.
SPL Price at posting:
$1.22 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)